top of page
Recent News & Press Releases
Search
Asha Therapeutics Awarded Barnett Drug Development Grant by the ALS Association and Announces Appointment of Disarm Therapeutics’ Founders to SAB
November 13, 2024 09:30 AM Eastern Standard Time CINCINNATI--( BUSINESS WIRE )-- Asha Therapeutics  (Asha), a life sciences company...
Business Wire
Nov 13, 20245 min read
Asha Therapeutics Announces the Nomination of a Novel Intra-Molecular Glue Development Candidate ASHA-624 as a Disease Modifying Therapeutic for Amyotrophic Lateral Sclerosis
CINCINNATI--(BUSINESS WIRE)--Asha Therapeutics (Asha) (www.ashatherapeutics.com), a life sciences company designing de novo disease...
Business Wire
Apr 1, 20243 min read
Asha Therapeutics to Present at AD/PDâ„¢ 2024 International Conference and Announces Clinical Development Plan for Lead Programs Anticipated to Enter Clinical Trials this Year
CINCINNATI--(BUSINESS WIRE)--Asha Therapeutics (Asha), (www.ashatherapeutics.com), a life sciences company, is leveraging its...
Business Wire
Mar 9, 20244 min read
Asha Therapeutics Selected as a BLUE KNIGHTâ„¢ Company by Johnson & Johnson Innovation and BARDA
Asha Therapeutics (Asha), (www.ashatherapeutics.com), a biopharmaceutical company revolutionizing the traditional multi-year drug...
PR Newswire
Sep 22, 20233 min read
Inside the Innovation Arena – A Recap of Our BLUE KNIGHT™ QuickPitch: Activating for the Future
August 31, 2023 - Earlier this week, innovation took center stage at the BLUE KNIGHTâ„¢ QuickPitch: Activating for the Future. 10...
JnJ Innovation
Sep 1, 20234 min read
Asha TX to present breakthrough data for ASHA-044 tareting Beta-Catenin in colorectal cancer at NGIO
Asha Therapeutics will be presenting new data at the 6th Annual Next-Gen Immuno-oncology Conference showing robust efficacy of their...
Asha TX
Jun 23, 20231 min read
bottom of page